CELESTENE 2 mg, scored dispersible tablet, box of 20

 Active ingredient

Betamethasone

 

CELESTENE is usually prescribed for:

Systemic lupus erythematosus

Systemic vasculitis

Polymyositis

Visceral sarcoidosis

Bullous pemphigus

Bullous pemphigoid

Infant angioma

lichen planus

Acute urticaria

Neutrophilic dermatosis

Ulcerative colitis

Crohn's disease

Autoimmune chronic active hepatitis

Severe acute alcoholic hepatitis

Severe De Quervain subacute thyroiditis

Hypercalcemia

Severe immunological thrombocytopenic purpura

Autoimmune hemolytic anemia

Lymphoid malignancy

Pure red cell aplasia

Congenital pure red cell aplasia

Tuberculous pericarditis

Life-threatening tuberculosis

Pneumocystis carinii pneumonitis with severe hypoxia

Antiemetic treatment during antineoplastic chemotherapy

Edematous and inflammatory growth associated with antineoplastic treatment

Nephrotic syndrome with minimal glomerular lesions

Nephrotic syndrome of primary segmental and focal hyalinosis

Lupus nephropathy

Intrarenal granulomatous sarcoidosis

Vasculitis with renal involvement

Primary extracapillary glomerulonephritis

Myasthenia gravis

Tumor cerebral edema

Polyradiculoneuritis

West syndrome

Lennox-Gastaut syndrome

Relapsed multiple sclerosis

Anterior uveitis

Posterior uveitis

Edematous proptosis

Optic neuropathy

Serous otitis

Nasosinus polyposis

Acute sinusitis

Chronic sinusitis

Seasonal allergic rhinitis

Subglottic laryngitis

Persistent asthma

Severe acute asthma

Chronic obstructive pulmonary disease

Active sarcoidosis

Diffuse interstitial pulmonary fibrosis

Rheumatoid arthritis

Polyarthritis

Polymyalgia rheumatica

Horton's disease

Acute articular rhumatism

Cervico brachial neuralgia

transplant rejection

Graft versus host reaction

Indications CELESTENE-

CONDITIONS OR DISEASES:

I- COLLAGENOSES-CONNECTIVITIES

Progressive outbreaks of systemic diseases including: systemic lupus erythematosus, vasculitis, polymyositis, visceral sarcoidosis.

II- DERMATOLOGICAL

a- severe autoimmune bullous dermatoses, in particular pemphigus and bullous pemphigoid

b- severe forms of angiomas in infants

c- certain forms of lichen planus

d- certain acute urticaria

e- severe forms of neutrophilic dermatoses

III- DIGESTIVES

a- progressive outbreaks of ulcerative colitis and Crohn's disease

b- autoimmune chronic active hepatitis (with or without cirrhosis).

c- severe acute alcoholic hepatitis, histologically proven

IV- ENDOCRINE

a- severe De Quervain's subacute thyroiditis

b- certain hypercalcemias

V- HEMATOLOGICAL

a- severe immunological thrombocytopenic purpuras

b- autoimmune hemolytic anemias

c- in combination with various chemotherapies in the treatment of lymphoid malignancies

d- chronic acquired or congenital erythroblastopenia

VI- INFECTIOUS

a- tuberculous pericarditis and severe forms of tuberculosis involving life-threatening

b- Pneumocystis carinii pneumonia with severe hypoxia

VII- NEOPLASTIC

a- antiemetic treatment during antineoplastic chemotherapy

b- edematous and inflammatory flare-up associated with antineoplastic treatments (radio and chemotherapy)

VIII- NEPHROLOGICAL

a- nephrotic syndrome with minimal glomerular lesions

b- nephrotic syndrome of segmental and focal primitive hyalinosis

c- stage III and IV of lupus nephropathy

d- intrarenal granulomatous sarcoidosis

e- vasculitis with renal involvement

f- primary extra-capillary glomerulonephritis

IX- NEUROLOGICAL

a- myasthenia gravis

b- cerebral edema due to tumor

c- chronic, idiopathic, inflammatory polyradiculoneuritis

d- infantile spasm (West syndrome) / Lennox-Gastaut syndrome

e- multiple sclerosis in flare, in relay of intravenous corticosteroid therapy

X- OPHTHALMOLOGICAL

severe anterior and posterior uveitis

b- edematous exophthalmos

c- certain optic neuropathies, following intravenous corticosteroid therapy (in this indication, the first-line oral route is not recommended)

XI- ENT

a- certain serous otitis

b- nasal polyposis

c- certain acute or chronic sinusitis

d- seasonal allergic rhinitis in short cure

e- Acute stridulous laryngitis (subglottic laryngitis) in children

XII- RESPIRATORY

a- persistent asthma preferably in short cure in case of failure of treatment by inhalation at high doses

b- exacerbations of asthma, in particular severe acute asthma

c- chronic obstructive pulmonary disease in evaluation of the reversibility of the obstructive syndrome

d- progressive sarcoidosis

e- diffuse interstitial pulmonary fibrosis

XIII- RHEUMATOLOGICAL

a- rheumatoid arthritis and certain polyarthritis

b- polymyalgia rheumatica and Horton's disease

c- acute articular rheumatism

d- severe and rebellious cervico-brachial neuralgia

XIV- ORGAN TRANSPLANTATION AND ALLOGENIC HEMATOPOIETIC STEM CELLS

a- prophylaxis or treatment of transplant rejection

b- prophylaxis or treatment of graft versus host disease